Adipose-Derived Stem Cells for Tissue Engineering and Regenerative Medicine Applications

The document reviewed the potential of adipose-derived stem cells (ASCs) in tissue engineering and regenerative medicine, emphasizing their accessibility and ability to differentiate into various cell types. ASCs were explored for applications in treating diseases like diabetes and multiple sclerosis, with 3D scaffolds enhancing their proliferation and differentiation. The review highlighted the importance of scaffold design, external stimuli, and growth factors in optimizing ASC applications. Despite promising results in laboratory studies and some clinical cases, challenges such as understanding ASC interactions, ensuring long-term safety, and limited clinical trials remained. The document concluded that further research and clinical trials were necessary to address these issues and fully realize the potential of ASCs in regenerative therapies.